Songbo Xie
机构：Tianjin Medical University Eye Hospital, Tianjin Medical University · ORCID：0000-0003-3195-6948
发表论文 82 篇 · 总被引 2278 次 · h-index 30
代表论文
- Targeted degradation of membrane and extracellular proteins with LYTACs (2024 · Acta Pharmacologica Sinica · 被引 56)
- Targeted protein degradation in drug development: Recent advances and future challenges (2023 · European Journal of Medicinal Chemistry · 被引 52)
- An engineered DNA aptamer-based PROTAC for precise therapy of p53-R175H hotspot mutant-driven cancer (2024 · 中国科学通报：英文版 · 被引 47)
- Targeted degradation of VEGF with bispecific aptamer-based LYTACs ameliorates pathological retinal angiogenesis (2024 · Theranostics · 被引 34)
- KIF11 UFMylation Maintains Photoreceptor Cilium Integrity and Retinal Homeostasis (2024 · Advanced Science · 被引 22)
- Design of PROTACs utilizing the E3 ligase GID4 for targeted protein degradation (2025 · Nature Structural & Molecular Biology · 被引 21)